Home » Topics » Disease categories and therapies » Immune

Immune
RSS

ICN-10776 reported at Immunology 2000 to induce Th2 cytokine bias

June 9, 2000

Roche scientists disclose new series of protein kinase inhibitors and their use

June 8, 2000

Selective EP2-binding agents and their therapeutic use claimed by Ono

June 8, 2000

Vical's cationic lipid formulation selectively enhances antibody immune response to antigen pDNA

June 7, 2000

Intellivax and Active Biotech form partnership to develop streptococcal vaccine

June 7, 2000

Efforts to develop malaria vaccines reviewed at ECCMID; new candidate from SB highlighted

June 2, 2000

Repligen acquires U.S. patent rights to CTLA4-Ig

June 2, 2000

Neisseria outer membrane proteins useful for the therapy, diagnosis of infections

June 1, 2000

Immunosuppressive and antitumor properties of new histone deacetylase inhibitor WF-27082B

May 31, 2000

Enzo Biochem's tolerance induction therapy may be useful in GVHD

May 31, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...